首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cancer innovation

缩写:

ISSN:2770-9191

e-ISSN:2770-9183

IF/分区:4.1/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引206
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Lixi Li,Yun Wu,Bo Lan et al. Lixi Li et al.
Background: The current standard of care for advanced human epidermal growth factor receptor 2 (HER2)-positive breast cancer is pertuzumab plus trastuzumab and docetaxel as first-line therapy. However, with the developmen...
Wei Chen,Haiyan Zhou,Mingyu Zhang et al. Wei Chen et al.
Background: The rate at which the anticancer drug paclitaxel is cleared from the body markedly impacts its dosage and chemotherapy effectiveness. Importantly, paclitaxel clearance varies among individuals, primarily becau...
Sahil Seth,Runzhe Chen,Yang Liu et al. Sahil Seth et al.
Background: Pulmonary sarcomatoid carcinoma (PSC) is a rare and aggressive subtype of non-small cell lung cancer (NSCLC), characterized by the presence of epithelial and sarcoma-like components. The molecular and immune l...
Enzhao Zhu,Linmei Zhang,Jiayi Wang et al. Enzhao Zhu et al.
Background: The role of surgery in metastatic breast cancer (MBC) is currently controversial. Several novel statistical and deep learning (DL) methods promise to infer the suitability of surgery at the individual level. ...
Huiyi Liu,Lu Fu,Shuyu Jin et al. Huiyi Liu et al.
Background: With the emergence of cytotoxic T lymphocyte-associated protein-4 (CTLA-4) inhibitors, the outcomes of patients with malignant tumors have improved significantly. However, the incidence of cardiovascular adver...
Ya-Xi Wu,Bing-Qian Li,Xiao-Qian Yu et al. Ya-Xi Wu et al.
Histone deacetylase 6 (HDAC6) belongs to a class of epigenetic targets that have been found to be a key protein in the association between tumors and cardiovascular disease. Recent studies have focused on the crucial role of HDAC6 in regula...
Wenhua Song,Nan Zhang,Tonglian Lv et al. Wenhua Song et al.
Background: Immune checkpoint inhibitors (ICI) are increasingly used in the first-line treatment of malignant tumors. There is increasing recognition of their cardiotoxicity and, in particular, their potential to lead to ...
Yulin Xu,Wei Shan,Qian Luo et al. Yulin Xu et al.
Background: Cancer-targeted T-cell receptor T (TCR-T) cells hold promise in treating cancers such as hematological malignancies and breast cancers. However, approaches to obtain cancer-reactive TCR-T cells have been unsuc...
Jing Chen,Jing Yang,Yufang Liu et al. Jing Chen et al.
Background: Angiogenesis plays an important role in the occurrence and development of non-small cell lung cancer (NSCLC). The atypical mitogen-activated protein kinase 4 (MAPK4) has been shown to be involved in the pathog...
Lu Peng,Yuan Gao,Zifeng Cao et al. Lu Peng et al.
Background: Disulfide, an essential compounds family, has diverse biological activity and can affect the dynamic balance between physiological and pathological states. A recently published study found that aberrant accumu...